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Table 1. Angiographic Characteristics of Lesions Treated with AXXESSTM
Target vessel
Left anterior descending/diagonal 23 (56%)
Left circumﬂex/obtuse marginal 11 (27%)
Right coronary artery/posterior descending 6 (15%)
Intermediate artery 1 (2%)
Medina classiﬁcation of the bifurcation lesion
1,0,0 6 (15%)
1,1,0 5 (12%)
1,1,1 21(51%)
0,1,1 4 (10%)
0,1,0 4 (10%)
0,0,1 1 (2%)
Angle between branches 4916
Radial access 26 (63%)
Pre-dilatation performed 41 (100%)
Pre-dilatation in proximal main vessel 39 (95%)
Pre-dilatation in distal main vessel 37 (90%)
Pre-dilatation in side branch 26 (63%)
AXXESSTM balloon size
3.0 mm 15 (37%)
3.5 mm 26 (63%)
AXXESSTM length
11 mm 16 (39%)
14 mm 25 (61%)
AXXESSTM delivered to
Main branch 36 (88%)
Side branch 5 (12%)
Combination of stents delivered
AXXESSTM only 4 (10%)
AXXESSTM and main branch only 18 (44%)
AXXESSTM and side branch only 1 (2%)
AXXESSTM, main branch and side branch 18 (44%)
Final kissing balloon 27 (66%)
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Background: Coronary artery by-pass graft (CABG) is the standard of care for
patients with unprotected left main stenosis (ULMS). Percutaneous coronary inter-
vention (PCI) is only recommended in speciﬁc anatomic conditions, such as low-mid
Syntax score (SS). It is unknown if the clinical and anatomic global risk classiﬁ-
cation (GRC) can enhance the indication of both revascularization therapies in those
patients.
Methods: A total of 407 patients with ULMS treated with CABG (n¼285) or PCI
(n¼122) were prospectively collected. The decision to treat with CABG or PCI was
dependent on patient and physician's choice. Patients with ST elevation myocardial
infarction, cardiogenic shock or valve disease were excluded. Clinical follow-up was
obtained at 3 years.
Results: Patients with low-GRC (n¼151) treated with CABG had a trend towards
higher cardiac mortality (5.9% vs. 0%; p¼0.165) and more major adverse cardiac
events (MACE) (18.5% vs. 12.5%; p¼0.397) than with PCI. Patients classiﬁed as
mid-GRC (n¼175) had similar cardiac death (11.1% vs. 10.3%; p¼0.849) and MACE
(20.7% vs. 22.4%; p¼0.921) with CABG or PCI, respectively. Patients with high-
GRC (n¼81) treated with CABG had a trend towards less cardiac death (16.3% vs.
28.1%; p¼0.155) and MACE (24.5% vs. 40.6%; p¼0.048) than with PCI. Statistical
models using the GRC as a predictor of cardiac death showed better goodness-of-ﬁt
than the anatomic SS.
Conclusions: At 3 years, patients with low and mid GRC have similar mid-term
outcomes either with CABG or PCI; patients with high-GRC seem to beneﬁt from
CABG. Although further investigations are required, GRC is a better predictor of
outcomes than SS.Device successfully delivered 41 (100%)
Device optimally placed 39 (95%)
Stent implantation proximal to AXXESSTM 12 (29%)
Number of stents implanted 2.851.0
Length of stents implanted (mm) 4724TCT-387
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Background: Percutaneous coronary intervention (PCI) of bifurcation lesions is
technically challenging and remains the focus of intense research. Currently, PCI of
the main vessel (MV) with provisional side branch (SB) stenting is the recommended
approach. However, not all bifurcation lesions can be treated with a one-stent tech-
nique. International societies have highlighted this problem stressing the need for
dedicated bifurcation stents. We describe an early UK experience of treating bifur-
cation lesions using a 7-French compatible self-expanding, nitinol-based, biolimus-
coated, AXXESSTM stent.
Methods: Patients with bifurcation lesions were prospectively enrolled in this
study. The AXXESSTM stent was deployed at the carina followed by drug eluting
stent (DES) deployment in the distal MV or SB if indicated. The procedures were
carried out by experienced operators with a special interest in bifurcation lesion
treatment.
Results: Forty one patients were treated with the AXXESSTM dedicated bifurcation
stent over a 14-month period. Eighty eight percent patients had true bifurcation
lesions and 90% patients required an additional stent in either the distal MV, SB or
both. In 29% of cases, a DES was deployed proximal to the AXXESSTM stent. The
device was successfully deployed in all cases while it was delivered in the optimal
position in 95% patients which translated into a lesion success rate of 100%. One
patient experienced a retroperitoneal bleed intra-procedurally leading to hypotension,
necessitating rapid case completion which contributed to sub-optimal AXXESSTM
stent placement.
Conclusions: Our data suggest that the AXXESSTM dedicated bifurcation stent can
be safely used and successfully delivered to treat selective bifurcation lesions with
high peri-procedural success rates. The results of this early UK experience are
encouraging and will help further the conﬁdence and capability to use this device.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions B121
